Sequence information
Variant position: 1460 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 2549 The length of the canonical sequence.
Location on the sequence:
FGELEIQATWYEKLHEWEDA
L VAYDKKMDTNKDDPELMLGR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human FGELEIQATWYEKLHEWEDAL VAYDKKMDTNKDDPELMLGR
Mouse FGELEIQATWYEKLHEWEDAL VAYDKKMDTNKEDPELMLGR
Rat FGELEIQATWYEKLHEWEDAL VAYDKKMDTNKDDPELMLGR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Literature citations
Somatic mutations in the MTOR gene cause focal cortical dysplasia type IIb.
Nakashima M.; Saitsu H.; Takei N.; Tohyama J.; Kato M.; Kitaura H.; Shiina M.; Shirozu H.; Masuda H.; Watanabe K.; Ohba C.; Tsurusaki Y.; Miyake N.; Zheng Y.; Sato T.; Takebayashi H.; Ogata K.; Kameyama S.; Kakita A.; Matsumoto N.;
Ann. Neurol. 78:375-386(2015)
Cited for: FUNCTION; INVOLVEMENT IN FCORD2; VARIANTS FCORD2 ASP-1459; PRO-1460; PHE-2215 AND TYR-2215; CHARACTERIZATION OF VARIANTS FCORD2 ASP-1459; PRO-1460; PHE-2215 AND TYR-2215;
Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy.
Moeller R.S.; Weckhuysen S.; Chipaux M.; Marsan E.; Taly V.; Bebin E.M.; Hiatt S.M.; Prokop J.W.; Bowling K.M.; Mei D.; Conti V.; de la Grange P.; Ferrand-Sorbets S.; Dorfmueller G.; Lambrecq V.; Larsen L.H.; Leguern E.; Guerrini R.; Rubboli G.; Cooper G.M.; Baulac S.;
Neurol. Genet. 2:E118-E118(2016)
Cited for: INVOLVEMENT IN FCORD2; VARIANTS GLU-1376 AND VAL-2501; VARIANTS FCORD2 SER-1459; PRO-1460; PHE-2215 AND TYR-2215; VARIANTS SKS ARG-1490; ILE-1595; THR-1832; CYS-1888 AND ILE-2327;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.